Cargando…
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions
[Image: see text] Tuberculosis remains a leading cause of death from a single bacterial infection worldwide. Efforts to develop new treatment options call for expansion into an unexplored target space to expand the drug pipeline and bypass resistance to current antibiotics. Lipoamide dehydrogenase i...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888283/ https://www.ncbi.nlm.nih.gov/pubmed/33527832 http://dx.doi.org/10.1021/acsinfecdis.0c00788 |
_version_ | 1783652130815475712 |
---|---|
author | Ginn, John Jiang, Xiuju Sun, Shan Michino, Mayako Huggins, David J. Mbambo, Zodwa Jansen, Robert Rhee, Kyu Y. Arango, Nancy Lima, Christopher D. Liverton, Nigel Imaeda, Toshihiro Okamoto, Rei Kuroita, Takanobu Aso, Kazuyoshi Stamford, Andrew Foley, Michael Meinke, Peter T. Nathan, Carl Bryk, Ruslana |
author_facet | Ginn, John Jiang, Xiuju Sun, Shan Michino, Mayako Huggins, David J. Mbambo, Zodwa Jansen, Robert Rhee, Kyu Y. Arango, Nancy Lima, Christopher D. Liverton, Nigel Imaeda, Toshihiro Okamoto, Rei Kuroita, Takanobu Aso, Kazuyoshi Stamford, Andrew Foley, Michael Meinke, Peter T. Nathan, Carl Bryk, Ruslana |
author_sort | Ginn, John |
collection | PubMed |
description | [Image: see text] Tuberculosis remains a leading cause of death from a single bacterial infection worldwide. Efforts to develop new treatment options call for expansion into an unexplored target space to expand the drug pipeline and bypass resistance to current antibiotics. Lipoamide dehydrogenase is a metabolic and antioxidant enzyme critical for mycobacterial growth and survival in mice. Sulfonamide analogs were previously identified as potent and selective inhibitors of mycobacterial lipoamide dehydrogenase in vitro but lacked activity against whole mycobacteria. Here we present the development of analogs with improved permeability, potency, and selectivity, which inhibit the growth of Mycobacterium tuberculosis in axenic culture on carbohydrates and within mouse primary macrophages. They increase intrabacterial pyruvate levels, supporting their on-target activity within mycobacteria. Distinct modalities of binding between the mycobacterial and human enzymes contribute to improved potency and hence selectivity through induced-fit tight binding interactions within the mycobacterial but not human enzyme, as indicated by kinetic analysis and crystallography. |
format | Online Article Text |
id | pubmed-7888283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-78882832021-02-18 Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions Ginn, John Jiang, Xiuju Sun, Shan Michino, Mayako Huggins, David J. Mbambo, Zodwa Jansen, Robert Rhee, Kyu Y. Arango, Nancy Lima, Christopher D. Liverton, Nigel Imaeda, Toshihiro Okamoto, Rei Kuroita, Takanobu Aso, Kazuyoshi Stamford, Andrew Foley, Michael Meinke, Peter T. Nathan, Carl Bryk, Ruslana ACS Infect Dis [Image: see text] Tuberculosis remains a leading cause of death from a single bacterial infection worldwide. Efforts to develop new treatment options call for expansion into an unexplored target space to expand the drug pipeline and bypass resistance to current antibiotics. Lipoamide dehydrogenase is a metabolic and antioxidant enzyme critical for mycobacterial growth and survival in mice. Sulfonamide analogs were previously identified as potent and selective inhibitors of mycobacterial lipoamide dehydrogenase in vitro but lacked activity against whole mycobacteria. Here we present the development of analogs with improved permeability, potency, and selectivity, which inhibit the growth of Mycobacterium tuberculosis in axenic culture on carbohydrates and within mouse primary macrophages. They increase intrabacterial pyruvate levels, supporting their on-target activity within mycobacteria. Distinct modalities of binding between the mycobacterial and human enzymes contribute to improved potency and hence selectivity through induced-fit tight binding interactions within the mycobacterial but not human enzyme, as indicated by kinetic analysis and crystallography. American Chemical Society 2021-02-02 2021-02-12 /pmc/articles/PMC7888283/ /pubmed/33527832 http://dx.doi.org/10.1021/acsinfecdis.0c00788 Text en © 2021 American Chemical Society Made available through a Creative Commons CC-BY-NC-ND License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) |
spellingShingle | Ginn, John Jiang, Xiuju Sun, Shan Michino, Mayako Huggins, David J. Mbambo, Zodwa Jansen, Robert Rhee, Kyu Y. Arango, Nancy Lima, Christopher D. Liverton, Nigel Imaeda, Toshihiro Okamoto, Rei Kuroita, Takanobu Aso, Kazuyoshi Stamford, Andrew Foley, Michael Meinke, Peter T. Nathan, Carl Bryk, Ruslana Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions |
title | Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford
Selectivity over the Human Enzyme through Tight Binding Interactions |
title_full | Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford
Selectivity over the Human Enzyme through Tight Binding Interactions |
title_fullStr | Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford
Selectivity over the Human Enzyme through Tight Binding Interactions |
title_full_unstemmed | Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford
Selectivity over the Human Enzyme through Tight Binding Interactions |
title_short | Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford
Selectivity over the Human Enzyme through Tight Binding Interactions |
title_sort | whole cell active inhibitors of mycobacterial lipoamide dehydrogenase afford
selectivity over the human enzyme through tight binding interactions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888283/ https://www.ncbi.nlm.nih.gov/pubmed/33527832 http://dx.doi.org/10.1021/acsinfecdis.0c00788 |
work_keys_str_mv | AT ginnjohn wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT jiangxiuju wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT sunshan wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT michinomayako wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT hugginsdavidj wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT mbambozodwa wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT jansenrobert wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT rheekyuy wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT arangonancy wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT limachristopherd wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT livertonnigel wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT imaedatoshihiro wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT okamotorei wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT kuroitatakanobu wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT asokazuyoshi wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT stamfordandrew wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT foleymichael wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT meinkepetert wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT nathancarl wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions AT brykruslana wholecellactiveinhibitorsofmycobacteriallipoamidedehydrogenaseaffordselectivityoverthehumanenzymethroughtightbindinginteractions |